These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8872326

  • 1. Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.
    Chen T, Dhingra K, Sahin A, Sneige N, Hortobagyi G, Aldaz CM.
    Breast Cancer Res Treat; 1996; 39(2):177-85. PubMed ID: 8872326
    [Abstract] [Full Text] [Related]

  • 2. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS, Hoare SF, Going JJ, Mallon EE, George WD, Kaye SB, Brown R, Black DM, Keith WN.
    J Natl Cancer Inst; 1995 Nov 15; 87(22):1694-704. PubMed ID: 7473818
    [Abstract] [Full Text] [Related]

  • 3. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
    Munn KE, Walker RA, Menasce L, Varley JM.
    Br J Cancer; 1996 Nov 15; 74(10):1578-85. PubMed ID: 8932338
    [Abstract] [Full Text] [Related]

  • 4. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization.
    Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, Höfler H, Werner M.
    Cancer Genet Cytogenet; 1999 Apr 15; 110(2):94-102. PubMed ID: 10214356
    [Abstract] [Full Text] [Related]

  • 5. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.
    Aldaz CM, Chen T, Sahin A, Cunningham J, Bondy M.
    Cancer Res; 1995 Sep 15; 55(18):3976-81. PubMed ID: 7664266
    [Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast.
    Ando Y, Iwase H, Ichihara S, Toyoshima S, Nakamura T, Yamashita H, Toyama T, Omoto Y, Karamatsu S, Mitsuyama S, Fujii Y, Kobayashi S.
    Cancer Lett; 2000 Aug 11; 156(2):207-14. PubMed ID: 10880771
    [Abstract] [Full Text] [Related]

  • 7. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA, Zhuang Z, Man Y, Park WS, Emmert-Buck M, Tavassoli FA.
    Mod Pathol; 1999 Dec 11; 12(12):1083-9. PubMed ID: 10619258
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Keohavong P, Gao WM, Mady HH, Kanbour-Shakir A, Melhem MF.
    Cancer Lett; 2004 Aug 20; 212(1):121-30. PubMed ID: 15246568
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR.
    Cancer Res; 1995 Feb 01; 55(3):467-71. PubMed ID: 7834608
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X, Porter AT, Honn KV.
    Adv Exp Med Biol; 1997 Feb 01; 407():41-53. PubMed ID: 9321930
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL.
    Lab Invest; 1994 Jul 01; 71(1):67-72. PubMed ID: 8041120
    [Abstract] [Full Text] [Related]

  • 20. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
    Shen KL, Yang LS, Hsieh HF, Chen CJ, Yu JC, Tsai NM, Harn HJ.
    J Surg Oncol; 2000 Jun 01; 74(2):100-7. PubMed ID: 10914818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.